Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ASCO News In Brief: Immunomedics CEA-Scan

Executive Summary

Immunomedics CEA-Scan: Diagnostic imaging agent shows 92% specificity rate in predicting which breast lesions were not cancerous in patients with inconclusive mammography findings requiring surgical biopsies. Results of the 42-patient study were reported by Dutzu Rosner, MD, State University of New York, Buffalo. In an 84-patient colorectal cancer study, CEA-Scan correctly diagnosed disease in 36 (61%) of the 59 patients who had a previous CT-negative scan. CEA-Scan became "approvable" on April 9 and the company says it is awaiting FDA approval of product labeling...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS028199

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel